Jeevan Scientific Technology Limited

JSTL6

INE237B01018

Biotechnology & Medical Research

Market Closed - Bombay S.E. Other stock markets 03:59:24 07/06/2024 pm IST			5-day change	1st Jan Change
51.87 ^INR	+3.78%		+4.64%	-15.49%

30/05	Jeevan Scientific Technology Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
11/03	Jeevan Scientific Technology Limited Announces Executive Changes, Effective March 31, 2024	CI

Jeevan Scientific Technology Limited Appoints K. Jeevan Krishna as Executive Director

August 12, 2022 at 06:16 pm IST

Jeevan Scientific Technology Limited announced that at its board meeting held on August 12, 2022, approved the appointment of Mr. K. Jeevan Krishna as Executive Director.

Latest news about Jeevan Scientific Technology Limited

Jeevan Scientific Technology Limited Reports Earnings Results for the Full Year Ended March 31, 2024	30/05	CI
Jeevan Scientific Technology Limited Announces Executive Changes, Effective March 31, 2024	11/03	CI
US FDA Clears Jeevan Scientific Technology's Bioanalytical Plant in Hyderabad, India	26/02	MT
Jeevan Scientific Technology Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13/11	CI
Jeevan Scientific Arm Ties Up with Aditri Pharm Sciences for Pharmaceutical Preparations	18/23/18	MT
Jeevan Scientific Technology Limited Announces Cessation of Surapaneni Sree Rama Koteswara Rao as Independent Director	29/23/29	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Jeevan Scientific Technology Limited Announces Resignation of Rama Krishna Prasad Kakarala as Non- Executive Director	12/23/12	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/23/27	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/23/08	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/23/08	CI
Nayas Laboratories Private Limited announced that it has received $20 million in funding from Jeevan Scientific Technology Limited	03/23/03	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	11/22/11	CI
Jeevan Scientific Technology Limited Declares Dividend for the Financial Year Ended March 31, 2022	29/22/29	CI
Jeevan Scientific Technology Names New CFO	15/22/15	MT
Jeevan Scientific Technology Limited Announces Executive Changes, Effective September 16, 2022	12/22/12	CI
Jeevan Scientific Technology Limited Appoints K. Jeevan Krishna as Executive Director	12/22/12	CI
Jeevan Scientific Technology Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12/22/12	CI
Jeevan Scientific Technology Appoints New COO	05/22/05	MT
Jeevan Scientific Technology Limited Appoints Chakrapani Majumdar as Chief Operating Officer	04/22/04	CI
Jeevan Scientific Technology CFO Steps Down	06/22/06	MT
Jeevan Scientific Technology Limited Announces Resignation of Srikanth Sasidhar as Chief Financial Officer	06/22/06	CI
Jeevan Scientific Technology Limited Recommends Final Dividend	30/22/30	CI
Jeevan Scientific Technology Limited Announces Management Changes	25/22/25	CI

Chart Jeevan Scientific Technology Limited

Duration

Period

Chart Jeevan Scientific Technology Limited

More charts

Jeevan Scientific Technology Limited is an India-based company, which provides technology-driven services and solutions to its clients across the globe. The Companyâs service portfolio enables its clients to provide an integrated solution for the management of clinical data from its inception to completion. The Company offers a range of clinical trial services from Phase II to IV for pharmaceutical, biotechnology and medical device to bring new drugs and devices into global reach faster. It also provides its services to other areas, such as cosmetics and nutraceuticals. Its clinical trial services include medical writing, clinical trial management, clinical trial monitoring, drug safety management, clinical data management, biostatistics and statistical programming, and quality assurance. It offers comprehensive pharmacovigilance and safety monitoring services from early development support through post-approval initiatives.

Sector

Biotechnology & Medical Research

Calendar

13/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
JEEVAN SCIENTIFIC TECHNOLOGY LIMITED	-15.49%	9.27M
MODERNA, INC.	+51.85%	59.28B
LONZA GROUP AG	+41.42%	40.94B
IQVIA HOLDINGS INC.	-5.25%	40.17B
CELLTRION, INC.	-5.16%	28.69B
ICON PUBLIC LIMITED COMPANY	+12.79%	26.63B
ALNYLAM PHARMACEUTICALS, INC.	-20.18%	18.89B
MEDPACE HOLDINGS, INC.	+30.88%	12.46B
BIO-TECHNE CORPORATION	+0.61%	12.42B
UNITED THERAPEUTICS CORPORATION	+25.06%	12.26B